Abstract:The aim of the present study was to find a way of prepare silybin–phospholipid complex to make oral bioavailability of silybin increase and to study its physicochemical properties and to compare the pharmacokinetic characteristics and bioavailability after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine in rats. Using ethanol as a reaction medium, silybin and phospholipids were resolved into the medium, after the organic solvent was removed under vacuum condition, silybin–phospholipid complex was formed. The new complex's physicochemical properties including scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), solubility, dissolution, etc., were tested. The concentrations of silybin after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine at different time in rats were determined by RP-HPLC. The pharmacokinetic parameters were computed by software program 3p97. Our data showed that silybin and phospholipids in the silybin–phospholipid complex were combined by non-covalent-bond, not forming a new compound and the solubility of silybin–phospholipid complex in water and in n-octanol was effectively enhanced. We found that mean plasma concentration–time curve of silybin after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine in rats was both in accordance with open single-compartment model with first-order absorption. Pharmacokinetic parameters of silybin in rats were Tmax 10 and 5 min; Cmax 126.72 and 104.29 ng ml−1; AUC0–∞ 1020.33 and 235.81 ng ml−1 h, respectively. The bioavailability of silybin in rats was increased remarkably after oral administration of silybin–phospholipid complex comparing to silybin-N-methylglucamine. This was mainly due to an impressive improvement of the lipophilic property of silybin–phospholipid complex and improvement of the biological effect of silybin.

Phytosomes as a Plausible Nano-Delivery System for Enhanced Oral Bioavailability and Improved Hepatoprotective Activity of Silymarin

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy

Comparative study of different silymarin formulations: formulation, characterisation and in vitro/in vivo evaluation

Enhancement of Oral Bioavailability of the Poorly Water-Soluble Drug Silybin by Sodium Cholate/phospholipid-Mixed Micelles

Silymarin nanoparticles through emulsion solvent evaporation method for oral delivery with high antioxidant activities, bioavailability, and absorption in the liver

Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects

Proliposomes for Oral Delivery of Dehydrosilymarin: Preparation and Evaluation in Vitro and in Vivo

Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method

The Preparation of Silybin–phospholipid Complex and the Study on Its Pharmacokinetics in Rats

Silymarin-Loaded Nanoparticles Based on Stearic Acid-Modified Bletilla striata Polysaccharide for Hepatic Targeting

Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation

Silybin Meglumine-Stabilized Nanosuspension Enhances the Therapeutic Efficacy of Silybin Against Hepatic Fibrosis

In Vitro Release and Bioavailability of Silybin from Micelle-Templated Porous Calcium Phosphate Microparticles

A comparative study on the preparation and evaluation of solubilizing systems for silymarin

Enhanced Bioavailability of Silymarin by Self-Microemulsifying Drug Delivery System

Preparation of Silymarin Proliposome: A New Way to Increase Oral Bioavailability of Silymarin in Beagle Dogs

Nanostructured calcium phosphate carriers for deliver of poor water-soluble drug silybin

Preparation of silymarin proliposomes and its pharmacokinetics in rats]

Advances in the Nanoparticle Drug Delivery Systems of Silymarin